Dronabinol is classified under which schedule of controlled substances?

Dronabinol, a medication that contains synthetic delta-9-tetrahydrocannabinol, is classified as a Schedule III controlled substance in the United States. The designation as Schedule III indicates that the substance has a recognized medical use and is considered to have a moderate potential for abuse compared to substances in lower schedules. While it can create dependency, the risks are lower than those associated with substances in Schedules I and II, which are more strictly regulated due to higher potential for abuse and addiction.

The classification takes into account both the therapeutic benefits of dronabinol in treating conditions such as nausea and vomiting associated with chemotherapy, as well as its potential for misuse. This balance of therapeutic value against the risk of abuse is a key factor in its Schedule III designation.